Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
Titel:
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelines
Auteur:
Phillips, Andrew N Bansi-Matharu, Loveleen Venter, Francois Havlir, Diane Pozniak, Anton Kuritzkes, Daniel R Wensing, Annemarie Lundgren, Jens D Pillay, Deenan Mellors, John Cambiano, Valentina Jahn, Andreas Apollo, Tsitsi Mugurungi, Owen Ripin, David Da Silva, Juliana Raizes, Elliot Ford, Nathan Siberry, George K Gupta, Ravindra K Barnabas, Ruanne Revill, Paul Cohn, Jennifer Calmy, Alexandra Bertagnolio, Silvia
Verschenen in:
The Lancet. HIV
Paginering:
Jaargang 7 () nr. 3 pagina's e193-e200
Jaar:
2020
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license